Alendronate once weekly for the prevention and treatment of bone loss in Canadian adult cystic fibrosis patients (CFOS trial).
Papaioannou A, Kennedy CC, Freitag A, Ioannidis G, O'Neill J, Webber C, Pui M, Berthiaume Y, Rabin HR, Paterson N, Jeanneret A, Matouk E, Villeneuve J, Nixon M, Adachi JD.
Chest. 2008 Oct;134(4):794-800. Epub 2008 Jul 18.PMID: 18641106 [PubMed - indexed for MEDLINE]Related articlesFree article